Participant flow

Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma · Source last updated 2025-05-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   BB2121

   id

   FG000

   title

   BB2121

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         77

      type

      Death

   2. reasons

      1. group Id

         FG000

         num Subjects

         4

      type

      Lost to Follow-up

   3. reasons

      1. group Id

         FG000

         num Subjects

         20

      type

      Withdrawal by Subject

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         137

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         36

      comment

      completed as per protocol

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         101

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

137 participants treated

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice